SUNY Downstate Council to Meet

May 17, 2013

For Immediate Release: Friday, May 17, 2013

Brooklyn – The SUNY Council of Downstate Medical Center will meet Monday, May 20, 2013 at 3:15 p.m. Topics for discussion will include an update on the development of a Sustainability Plan for Downstate Medical Center.

The meeting will take place at:

SUNY Downstate Health Sciences University
Alumni Auditorium
395 Lenox Road
Brooklyn, New York

Video conferencing will be available from the following location(s):

State University Plaza
353 Broadway
Albany, New York

The live webcast may be viewed at:

http://mediasite.suny.edu/mediasite/Viewer/?peid=32925106fe974ea4ad1678ccce58fdfd1d .

An agenda for the meeting, together with any meeting materials, will available online at www.downstate.edu.

###

About SUNY Downstate Health Sciences University

Downstate Health Sciences University in Brooklyn is one of four academic health centers (AMCs) in The State University of New York (SUNY) 64-campus system and the only SUNY AMC in New York City dedicated to health education, research, and patient care for the borough’s 2.7 million residents. Its flagship hospital, University Hospital at Downstate (UHD), is a teaching hospital and benefits from the expertise of Downstate’s exceptional medical school and world-class academic center research facilities. With a staff of over 800 physicians representing 53 specialties and subspecialties, Downstate offers comprehensive healthcare services to the community.

UHD provides high-risk neonatal and infant services, pediatric nephrology, and dialysis for kidney diseases and is the only kidney transplantation program in Brooklyn. Beyond its clinical expertise, Downstate houses a range of esteemed educational institutions, including its College of Medicine, College of Nursing, School of Health Professions, School of Graduate Studies, and School of Public Health. Downstate fosters innovation through its multifaceted biotechnology initiative, the Biotechnology Incubator and BioBAT, which support early-stage and more mature biotech companies.